These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17199853)

  • 21. Inflammation in the etiology of prostate cancer: an epidemiologic perspective.
    Sutcliffe S; Platz EA
    Urol Oncol; 2007; 25(3):242-9. PubMed ID: 17483023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variability in inflammation pathways and prostate cancer risk.
    Sun J; Turner A; Xu J; Grönberg H; Isaacs W
    Urol Oncol; 2007; 25(3):250-9. PubMed ID: 17483024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [MEDICAL AND SURGICAL MANAGEMENT OF PROSTATIC DISEASE].
    ALVAREZIERENAJDE J; FLORES A; GARCIAIRIGOYEN C
    Rev Med Hosp Gen (Mex); 1963 Oct; 26():721-40. PubMed ID: 14096981
    [No Abstract]   [Full Text] [Related]  

  • 24. Oestrogens and prostate cancer: novel concepts about an old issue.
    Briganti A
    Eur Urol; 2009 Mar; 55(3):543-5. PubMed ID: 19095344
    [No Abstract]   [Full Text] [Related]  

  • 25. Pleiotropic functional properties of androgen receptor mutants in prostate cancer.
    Bergerat JP; Céraline J
    Hum Mutat; 2009 Feb; 30(2):145-57. PubMed ID: 18800375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Androgens and prostate: basic research and clinical data].
    Martini PM; Rossi D; Muracciole X; Saussine C; Raynaud JP; Tostain J
    Prog Urol; 2004 Nov; 14(5):751-67. PubMed ID: 15747623
    [No Abstract]   [Full Text] [Related]  

  • 28. Androgens and the molecular epidemiology of prostate cancer.
    Chu LW; Reichardt JK; Hsing AW
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):261-70. PubMed ID: 18438175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perinatal imprinting by estrogen and adult prostate disease.
    Söder O
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1269-70. PubMed ID: 15677320
    [No Abstract]   [Full Text] [Related]  

  • 30. [Role of androgen in prostate carcinogenesis].
    Ide H; Horie S
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():61-5. PubMed ID: 22207943
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostate inflammation and its potential impact on prostate cancer: a current review.
    Haverkamp J; Charbonneau B; Ratliff TL
    J Cell Biochem; 2008 Apr; 103(5):1344-53. PubMed ID: 17955503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathway.
    Pandini G; Genua M; Frasca F; Vigneri R; Belfiore A
    Ann N Y Acad Sci; 2009 Feb; 1155():263-7. PubMed ID: 19250214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen deprivation increases p300 expression in prostate cancer cells.
    Heemers HV; Sebo TJ; Debes JD; Regan KM; Raclaw KA; Murphy LM; Hobisch A; Culig Z; Tindall DJ
    Cancer Res; 2007 Apr; 67(7):3422-30. PubMed ID: 17409453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of serum ceruloplasmin levels in prostate diseases: preliminary investigation of the effect of therapeutic estrogens on serum levels of this protein].
    Bélanger L
    Union Med Can; 1971 Aug; 100(8):1554-62. PubMed ID: 5561247
    [No Abstract]   [Full Text] [Related]  

  • 35. Herbal/hormonal dietary supplement possibly associated with prostate cancer progression.
    Shariat SF; Lamb DJ; Iyengar RG; Roehrborn CG; Slawin KM
    Clin Cancer Res; 2008 Jan; 14(2):607-11. PubMed ID: 18223237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen action on the prostate gland: a critical mix of endocrine and paracrine signaling.
    Risbridger GP; Ellem SJ; McPherson SJ
    J Mol Endocrinol; 2007 Sep; 39(3):183-8. PubMed ID: 17766643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidimensional approaches in dealing with prostate cancer.
    Ali S; Ali S
    Gene; 2008 Feb; 410(1):1-8. PubMed ID: 18226472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century.
    McGrath KG
    Med Hypotheses; 2009 Jun; 72(6):665-74. PubMed ID: 19307063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.
    Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
    Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen signaling and its interactions with other signaling pathways in prostate cancer.
    Kaarbø M; Klokk TI; Saatcioglu F
    Bioessays; 2007 Dec; 29(12):1227-38. PubMed ID: 18008377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.